Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 572 participants.
Also called NCT07253181
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 572 participants
- Sponsor
- Registry
-
NCT07253181
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07253181. Randomized; single masking; primary purpose treatment. Start 2026-01-06 (actual); primary completion 2028-03-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours
- Acronym
- TREASURE
- Condition
- Acute Ischemic Stroke
- Condition
- Large Vessel Occlusion
- Condition
- Transportation of Patients
- Intervention (Drug)
- Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
- Lead sponsor
- Xuanwu Hospital, Beijing
- Collaborator
- Boehringer Ingelheim (China) Investment Co., Ltd
- Collaborator
- Jeffrey Saver
- Collaborator
- Maarten Lansberg
- Collaborator
- Thanh N. Nguyen
- Collaborator
- Pierre Seners
- Collaborator
- Jens Fiehler
- Collaborator
- Raul G. Nogueira
Record details
- Record id
cardio:ct-nct07253181- Content hash
7c50cce24cd346b9d926eadc91690d4bcb6dc59036f4c5c111dfda3cf3d222b5